04 June 2007
Comparative outcome of trebeculectomy glaucoma surgery (right eye) versus microtrephination glaucoma surgery (left eye) in an undiagnosed keloid former
Joseph Momodu Waziri-Erameh , Afekhide Ernest OmotiCase Rep Clin Pract Rev 2007; 8:139-142 :: ID: 485022
Abstract
Background: Glaucoma is the second leading cause of blindness in sub-Saharan Africa after cataract. The standard treatment is trabeculectomy. However, higher fibroblast activities in Blacks and Asians from more vigorous tissue reactions to trauma including surgical trauma, cause filtering glaucoma procedures to fail more in Blacks than in Caucasians. This report shows the
advantage of microtrephination over trabeculectomy in a Keloid former with glaucoma.
Case Report: One male glaucoma patient had trabeculectomy in the right eye and microtrephination in the left eye at the University of Benin Teaching Hospital, Benin-city, Nigeria. He was not known to be a Keloid former at the time of surgery. Trabeculectomy failed to control the intraocular pressure in the right eye under 6 months and had to be repeated twice before it was discovered that the patient was a keloid former. Microtrephination was able to control and keep the intraocular below 20 mmHg in the other eye (left eye) for at least 2 years before he was lost to follow-up.
Conclusions: Microtrephination may be a more effective procedure than trabeculectomy in controlling intraocular pressure in glaucoma patients who are keloid formers.
Keywords: Glaucoma, microtreplination, Trabeculectomy, keloid
444
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






